Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженсан Биофарма, Инк.filedCriticalДженсан Биофарма, Инк.
Priority claimed from PCT/US2019/039994external-prioritypatent/WO2020006516A1/en
Publication of EA202092931A1publicationCriticalpatent/EA202092931A1/en
Описаны противоопухолевые антагонисты, которые специфично связываются с регулятором иммунных контрольных точек. Также описан способ лечения пролиферативных расстройств с помощью противоопухолевых антагонистов.Antitumor antagonists have been described that specifically bind to an immune checkpoint regulator. Also described is a method of treating proliferative disorders using antitumor antagonists.
EA202092931A2019-03-262019-06-28
ANTITUMOR ANTAGONISTS OF IMMUNE CONTROL POINT REGULATORS
EA202092931A1
(en)